ClinicalTrials.govpublic full text
Vandetanib and Sirolimus in Patients With Recurrent Glioblastoma
glioblastoma, vandetanib, sirolimus, recurrent glioblastoma, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 917952
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.